Skip to content

Clinical trials

Phase 1 Diabetic Retinopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetic Retinopathy Phase: Phase 1 Country / region: United States Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20051
20064
20071
20083
20122
20152
20162
20182
20191
20201
20222
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting3
Terminated2
Enrolling by invitation1
Active, not recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Eye Institute (NEI)5
Medical College of Wisconsin2
ThromboGenics2
Aerie Pharmaceuticals1
Hermann Eye Center1
Hoffmann-La Roche1
Manhattan Eye, Ear & Throat Hospital1
MediBeacon1
PanOptica, Inc.1
Retina Research Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetic Retinopathy28
Diabetes Mellitus8
Macular Degeneration6
Macular Edema5
Retinal Diseases5
Retinal Vein Occlusion3
Choroidal Neovascularization2
Inflammation2
Retinitis Pigmentosa2
Diabetes Mellitus, Type 11

Trials

Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.